ABSTRACT. We investigated whether de-differentiated fat (DFAT) cells, a mature adipocyte-derived preadipocyte cell line, can be induced to trans-differentiate into osteoblasts in vitro and in vivo. All-trans retinoic acid (RA) induced expression of osteoblast-specific mRNAs encoding Cbfa1/Runx2, osterix, alkaline phosphatase, osteopontin, parathyroid hormone receptor, and osteocalcin in the DFAT cells, but did not induce the expression of adipocytespecific mRNAs encoding PPARγ2, C/EBPα, and GLUT4. Moreover, alkaline phosphatase activity was expressed in DFAT cells and the cells underwent mineralization of the bone matrix in vitro. Furthermore, when DFAT cells were transplanted subcutaneously into C57BL/6N mice in diffusion chambers, these cells formed ectopic osteoid tissue without any host cell-invasion of the chambers. These results indicate that DFAT cells derived from mature adipocytes can be converted into fully differentiated osteoblasts in vitro and in vivo using RA. DFAT cells provide a unique model for studying the lineage commitment of the adipocytes and osteoblasts derived from mesenchymal stem cells. Identification of the pathways that regulate these processes could lead to the development of new therapeutic strategies for control of unwarranted growth of bone and adipose tissue.
Introduction
Osteoblasts and adipocytes have a common origin-mesenchymal stem cells (MSCs) (Pittenger et al., 1999; Prockop, 1997) . The progenitors differentiate into mature functional cell types by subsequent terminal differentiation, and can neither de-differentiate nor re-enter mitosis (Wang and Scott, 1993; Wier and Scott, 1986) . Activation of defined transcription factors and the repression of others is essential for a cell's commitment to a specific differentiation lineage, thus setting the stage for a gene expression pattern characteristic for that particular cell type (Black and Olson, 1998; de Cronbrugghe et al., 2000; Rosen et al., 2000; Wagner and Karsenty, 2001 ). Runt-related transcription factor 2 (RUNX2) and osterix (OSX) are osteogenic transcription factors necessary for early and late differentiation of osteoblasts, and their expression is stimulated by bone morphogenetic protein-2 (BMP-2) (Lee et al., 1999 (Lee et al., , 2003a Nakashima et al., 2002) . Adipocyte differentiation is mediated by the expression and activation of at least two families of transcription factors, CAAT/enhancer-binding proteins (C/ EBPs) α, β, and δ, and the peroxisome proliferatoractivated receptor gamma (PPARγ), which is expressed as two isoforms, PPARγ1 and the adipocyte-specific PPARγ2, and their expression in turn is stimulated by the synthetic glucocorticoid dexamethasone (Hausman, 2003; Shao and Lazar, 1997) . These specific transcriptional factors control the differentiation of osteoblasts and adipocytes derived from common MSCs.
Retinoids, a group of natural and synthetic analogs of retinol (vitamin A), have essential roles during embryogenesis, and have profound effects on the differentiation and proliferation of cells (Ross, 1993; Gudas et al., 1994; Ross et al., 2000) . The biological effects of retinoid signaling are primarily mediated by retinoic acid receptors (RARs) and retinoid X receptors (RXRs), members of the nuclear receptor superfamily that act as ligand-inducible transcription factors Mangelsdorf et al., 1995) . Alltrans-retinoic acid (RA), the most potent retinoid, binds with RARs and RXRs and activates them. RA has essential roles in the regulation of the adipogenesis of preadipocyte cell lines (Ohyama et al., 1998) and osteoblasts (Leboy et al., 1991; Gazit et al., 1993) . The 3T3-L1 and its subclonal cell 3T3-F442A cell lines are committed to adipogenic lineage, and they spontaneously accumulate lipids and differentiate into mature adipocytes upon growth arrest making them extremely useful in in vitro studies of adipocyte differentiation (Green and Meuth, 1974; Kehinde, 1975, 1976) . Exogenous application of RA to 3T3-F442A or 3T3-L1 preadipocytes inhibits adipogenic differentiation and lipid accumulation (Kuri-Harcuch, 1982; Schwarz et al., 1997) . RA is known to promote the differentiation of primary osteoblasts in vitro, resulting in enhanced expression of osteogenic genes (e.g., alkaline phosphatase (ALP), osteocalcin (OC), osteopontin) and ultimately leading to deposition of bone nodules (Ng et al., 1988; Heath et al., 1989; González and Martin, 1996; Nuka et al., 1997; Song et al., 2005) . RA and bone morphogenetic proteins (BMPs) signaling work cooperatively to repress adipogenesis and promote osteoblast differentiation in 3T3-F442A cells (Skillington et al., 2002) . These reports suggested that adipogenic progenitor cells committed to one defined lineage can be persuaded to trans-differentiate into an osteoblastic lineage.
Mature adipocytes that have a large single lipid droplet are generally considered stationary cells in the terminal stage of differentiation that have lost their proliferative ability (Johnson and Goldstein, 1983; Van, 1985) . We previously established that the preadipocyte cell line, dedifferentiated fat (DFAT) cells, originate from the mature adipocytes of mouse subcutaneous fat tissue (Yagi et al., 2004; Nobusue et al., 2008) . DFAT is a unique preadipocyte cell line that has experience in terminal differentiation as mature adipocytes. DFAT cells express the early markers of adipocyte differentiation, i.e., SREBP-1c, LPL, and C/ EBPβ and δ, before adipogenic induction (Nobusue et al., 2008) . In this study, we ascertained whether preadipocytes that have terminally differentiated into the adipocytic lineage can be persuaded to trans-differentiate into the osteoblastic lineage.
We demonstrated that RA induced osteoblastic differentiation, via expression of RUNX2 and OSX followed by an increase in PTHr1 and OC without inducing adipogenic differentiation, via expression of PPARγ2 and C/EBPs followed by induction of GLUT4 expression in DFAT cells. DFAT cells can undergo terminal osteoblast differentiation, matrix mineralization in vitro, and osteoid matrix formation, following subcutaneous injection into the peritoneal cavity of C57BL/6N mice.
Materials and Methods

Cell culture
The mouse osteoblast cell line, MC3T3-E1 (positive control cell), was obtained from RIKEN Cell Bank (Tsukuba, Japan). DFAT preadipocytes and MC3T3-E1 were placed in a tissue culture dish (BD Falcon 3001, Bedford, MA, USA) with Dulbecco's modified Eagle's medium (DMEM; Nissui Pharmaceutical Co., Tokyo, Japan) supplemented with 10% fetal bovine serum (FBS; Moregate BioTech, Bulimba QLD, Australia). The medium was changed every four days until the cells were used, and then incubated at 37°C in a humidified atmosphere of 5% CO2. DFAT cells were grown to semi-confluence for differentiations. Osteogenic differentiation was induced by changing the medium to DMEM supplemented with 10% FBS 10 μM all-trans retinoic acid (RA; Sigma Aldrich, Tokyo, Japan) with or without 50 mM β-glycerophosphoric acid (bGP; Wako Pure Chemical Industries, Osaka, Japan). After 96 h, differentiation medium was replaced with DMEM supplemented with 10% FBS with or without bGP. For osteoblastic maturation studies, MC3T3-E1 cells were cultured in DMEM medium with 10% FBS supplemented with 50 μg/mL ascorbic acid (Sigma, St. Louis, MO, USA) and 10 mM bGP for 16 days. Adipogenic differentiation was induced by changing the medium to DMEM supplemented with 10% FBS, 0.5 mM 3-isobutyl-1-methylxanthine (MIX; Wako), 0.1 μM dexamethasone (DEX; Wako), and insulin-transferrin-selenium-X supplement containing 5 μg/mL insulin (ITS; Invitrogen, Carlsbad, CA, USA). Differentiation medium was replaced with DMEM supplemented with 10% FBS after 96 h.
Lipid accumulation assay
Lipid accumulation in adipocytes was visualized by staining with Oil Red O (ORO; Wako) as described previously (Nobusue et al., 2008) . Cells were washed thrice with phosphate-buffered saline (PBS) followed by fixation with 4% formalin in phosphate buffer for 1 h at room temperature. After fixation, the cells were washed once with PBS and stained with a filtered ORO stock solution (0.5 g of ORO in 100 mL isopropyl alcohol) for 15 min at room temperature. Cells were washed twice with H2O for 15 min.
To quantify lipid accumulation, 500 μL/35 mm dish of dimethyl sulfoxide (DMSO; Wako) was added to each washed and dried stained well. Stained lipid was allowed to extract for 1 min. Extracted ORO absorbance was read at 510 nm on a spectrophotometer (ND-1000; Nanodrop Technologies, Inc., Wilmington, DE, USA) and was normalized to dish area.
Assay to measure ALP activity
For ALP activity in the osteoblasts to be visualized, the cells were rinsed on 35-mm tissue culture dishes with PBS. They were stained with staining buffer, including 1% of 16 mg/mL naphthol AS-TR phosphate sodium salt (Sigma) in N,N-dimethylformamide (Wako) and Fast Blue BB Salt (Wako) in 0.1 mol Tris-HCl at 37°C for 1 h and then rinsed with distilled water. ALP activity of the total cell layer was measured in parallel dishes after extraction in cell digestion buffer (1.5 M Tris-HCl, 1 mM ZnCl2, 1 mM MgCl2, pH 9.8) containing 1% Triton X-100 at room temperature for 10 min. Aliquots of the cell digest were mixed with assay buffer containing 6.7 mM p-nitrophenol and were monitored for absorbance at 405 nm over a 15-min time period. Enzyme activity was expressed as unit (nmol p-nitrophenol formed/μL/min)/ng protein. Protein content was determined using Bio-Rad protein assay solution (Bio-Rad Laboratories, Hercules, CA, USA).
Calcium deposition assay
After fixation with 4% formalin in phosphate buffer for 1 h at room temperature, the cells were incubated in 5% silver nitrate (Wako) for 1 h under ultraviolet light, and then rinsed with distilled water. Secretion of calcified extracellular matrix was confirmed as black nodules with von Kossa staining. To quantify calcium deposition, the cells were washed twice with PBS and treated with 2 N HCl overnight. Calcium concentrations in HCl supernatants were determined by calcium C-test kit (Wako) as described previously (Tanabe et al., 2004) , normalized to dish area, and expressed in mg per 35 mm culture dish.
ELISA for quantification of OC
Confluent DFAT cells were cultured in DMEM containing 10% FBS for the indicated period in the presence or absence of the indicated concentrations of RA. Culture media were collected on day 4, 8, 12, and 16. Concentrations of OC in culture media of the cells 
RNA extraction
Total RNA was isolated from the DFAT and MC3T3-E1 cells before and after differentiation stimuli using TRIzol reagent (Invitrogen Corp., Carlsbad, CA, USA) according to the manufacturer's instructions.
Reverse transcription-polymerase chain reaction (RT-PCR) analysis
Gene expression levels were estimated by RT-PCR. Total RNA (1 μg) digested with DNase I was subjected to RT-PCR analysis. Total RNA was reverse-transcribed by SuperScript III (Invitrogen) with random hexamer (Invitrogen). Reverse-transcripts were used as templates for analysis of the gene expression levels using PX2 Thermal Cycler (Hybaid Ltd., Middlesex, UK) and AmpliTaq Gold (Applied Biosystems, Foster City, CA, USA) according to the manufacturer's instructions. In general, PCR primers were designed to amplify 200-500 bp of the target sequences. Primer sequences are described in Table 1 . PCR conditions were as follows: 5 min at 94°C followed by 30 cycles of 30 s at 94°C, 30 s at 55°C (GLUT4), 58°C (RUNX2; ALP; OP; PTHr1; C/EBP β, δ, and α; PPARγ2; and GAPDH), 63°C (OSX, OC, BMP2, BMPRIA, BMPRIB, and BMPRII) and 1 min at 72°C, with a final elongation step of 5 min at 72°C. Aliquots of PCR product were analyzed on 2% ethidium bromide-stained agarose gel.
Transplantation and histological evaluation
All studies were carried out according to the NIH guidelines for the care and treatment of experimental laboratory rodents. C57BL/6N mice were purchased from Charles River (Tokyo, Japan). Diffusion chambers were assembled from commercially available components (inner diameter 10 mm; thickness, 2 mm; Millipore Corp., Bedford, MA, USA) and membrane filters (pore size, 0.45 μm; Millipore Corp.). After attachment of membrane filters to both sides of the diffusion chamber with adhesive, they were sterilized at 80°C for 24 h. To investigate the calcification of DFAT cells after transplantation, cells that had not formed a mineralized matrix four days after osteogenic induction were used for transplantation (Fig. 2Ab, g and 2B) . These cells were collected with a cell scraper. A suspension of 1×10 6 cells in 100 μL of type-1 collagen gel (Nitta Gelatin, Osaka, Japan) was injected into the diffusion chamber using a syringe. They were transplanted into the peritoneal cavity of 8-week-old female mice (one diffusion chamber per mouse). Four weeks later, the diffusion chamber were removed, fixed in 4% neutral buffered formalin, and embedded in paraffin. Four-micron sections were prepared, stained by von Kossa and counterstained with light-green and hematoxylineosin for visualization of mineralization.
Statistical analyses
Data were analyzed for statistical significance by one-way analysis of variance (ANOVA). A value of P<0.01 was considered statistically significant. All the experiments were repeated three times.
Results
RA stimulation induces ALP activity and matrix mineralization in DFAT cells in vitro
DFAT cells were cultured in RA supplemented medium with 50 mM β-glycerophosphoric acid. Enzyme activity levels of ALP were analyzed by histologic staining and spectrophotometry to characterize their osteogenic differentiation. RA induced ALP activity in DFAT cells, suggesting that these cells have the potential to differentiate into osteoblasts (Fig. 1) . DFAT cells did not have ALP activity before RA stimulation (Fig. 1Aa, f and 1B) . After RA stimulation, several ALP-positive cells were observed (Fig. 1Ab, g ). By day 4, the increase in ALP activity was rapid and significant (p<0.01), peaking on day 4, and decreased through the late stage of the osteogenic process (Fig. 1B) . No significant difference in the total amount of protein was observed between the control and RA-treated cells during the osteogenic process (data not shown). DFAT cells were examined for their ability to undergo extracellular matrix (ECM) mineralization. Matrix mineralization was visualized using von Kossa staining and quantified using calcium C-test by culturing in the presence of β-glycerophosphate. Fig. 2A shows von Kossa staining in DFAT cells after RA stimulation. Microscopic analysis of RA-treated cells confirmed weakly mineralized regions 8 days after osteogenic induction (Fig. 2Ac,  h ). Bone nodules were observed after 12 days and they gradually increased up to the 16 th day (Fig. 2Ad , e, i, j). Matrix mineralization was significantly increased in the DFAT cells after osteogenic induction (Fig. 2B) . Osteogenic differentiation of DFAT cells was evaluated by measuring the amount of OC in the ECM. OC is a noncollagenous calcium-binding bone protein secreted from osteoblasts, and is regarded as a marker of late-stage osteogenic differentiation. OC production was accompanied by an increment of matrix mineralization in a time-dependent manner, and was significant (p<0.01) on the 16 th day after osteogenic induction (Fig. 2C) . These results revealed that RA is efficient in completely converting DFAT cells to mature osteoblasts.
RA does not induce DFAT adipogenic differentiation
Oil Red O staining and colorimetric determination of lipid accumulation was used to ascertain if RA does not induce adipogenic differentiation in DFAT cells.
Treatment of DFAT cells with an adipogenic cocktail induced adipogenic differentiation with accumulation of lipids, and full differentiation after 16 days (Fig. 3Ab, d ). RA treatment did not induce the ability of DFAT cells to undergo adipocyte differentiation (Fig. 3A) . This noninduction was apparent by a reduction of lipid-filled adipocytes and a fibroblastic morphology (Fig. 3Aa, c) similar to control cells (data not shown) observed microscopically. Colorimetric determination by atomic absorbance spectrophotometry at 510 nm showed that lipid accumulation increased significantly in adipogenic-induced DFAT cells compared to that in control cells (Fig. 3B) . RA did not induce lipid accumulation at the same level as that in control cells (Fig. 3B ). These data indicate that RA inhibited adipogenic differentiation in DFAT cells.
Effect of RA on mRNA expression of osteogenic and adipogenic transcription factors and their differentiation markers
With regard to cell phenotype, RA did not induce adipocyte differentiation, whereas osteoblast differentiation was promoted in DFAT cells. We determined its effect on the mRNA expression levels of adipogenic and osteogenic transcription factors, and their differentiation markers were analyzed by RT-PCR. Early, middle, and late markers for osteogenic and adipogenic differentiation were assessed on day 0, 4, 8, 12, and 16 from cells cultured in osteogenic medium (OM) with 50 mM β-glycerophosphoric acid and adipogenic medium (AM). Fig. 4A shows the gene expression pattern of osteogenic markers during osteogenic differentiation. The density of the amplified cDNA band for some adipogenic markers was normalized with respect to the density of the corresponding band for GAPDH. From the begin- ning of the confluence phase, the expression of RUNX2, OP, PTHr1, and OC mRNA was detected in DFAT cells, and was upregulated after osteogenic stimulation (Fig. 4A) . Time-dependent experiments revealed the gene expression peaks of ALP, OSX, and BMP2 mRNA during the period of osteogenic differentiation; ALP mRNA level peaked at 4 days, and OSX and BMP2 mRNA levels peaked at 12 days (Fig. 4A) . RA did not upregulate the expression levels of adipogenic transcription factors and their differentiation markers in DFAT cells. PPARγ2, C/EBPα, and GLUT4 were not detected in RA-treated cultures, despite maintaining the mRNA expression of C/EBPβ and δ. These results indicated that RA repressed adipocyte differentiation and enhanced osteoblast differentiation on mRNA expression levels.
Formation of osteoid tissue by transplanted DFAT cells
We carried out a transplantation experiment using a diffusion chamber system to investigate if DFAT can form osteoid tissue in vivo. Calcium deposits were not detected in control DFAT cultures, or in skin fibroblasts, either treated or not (cell negative controls; data not shown). Harvested cells were suspended in type-I collagen gel and injected into a diffusion chamber. Constructs were transplanted subcutaneously into mice. Four weeks after transplantation, scattered areas of bone were observed after von Kossa, light green, and hematoxylin-eosin staining (Fig. 5) . The diffusion chamber system showed that the osteoid tissues that had formed after transplantation were derived from DFAT cells. The DFAT cells were implanted subcutaneously into the host animals, and were distinguished from the host cells using filter. . Timedependent effect of RA stimulation on mRNA expression of the adipogenic transcription factors, C/EBPs and PPARγ2, and on that of the late adipogenic marker GLUT4. C/EBPβ and δ mRNA expressions were determined by RT-PCR, but those of C/EBPα, PPARγ2, and GLUT4 were not. The density of each amplified cDNA band for some osteogenic and adipogenic markers was normalized to the density of the corresponding band for GAPDH. Abbreviations: OM, osteogenic medium; AM, adipogenic medium.
RA-pretreated DFAT cells that were cultured with or without β-glycerophosphate (bGP) prior to injection had formed osteoid tissue in a diffusion chamber at the transplantation site (Fig. 5c , e) but control cells had not (Fig. 5a, d ). DFAT cells that were cultured without bGP had also formed osteoid tissue (Fig. 5b) . Taken together, these data indicate that RA-treated DFAT can form ectopic osteoid tissue without host cells.
Discussion
Several studies have demonstrated that mesenchymal progenitor cells (MPCs) from various tissues have the potential to differentiate into other cells (Katagiri et al., 1994; Ito et al., 2007; Sudo et al., 2007) , suggesting that pre-committed and committed cells have plasticity in cell fate determination. How far the lineage-specific cells can be persuaded to trans-differentiate into another lineage remains unknown.
We investigated whether DFAT cells that had terminally differentiated into the adipocytic lineage could be induced by RA to trans-differentiate into the osteoblastic lineage. Our results revealed the following: (1) DFAT cells can be converted into mature osteoblasts that can undergo calcification in vitro, (2) RA stimulation not only promotes osteogenesis, but also represses adipogenesis in DFAT cells, and (3) DFAT cells form new osteoid tissue ectopically in subcutaneous spaces without host cells. These results indicated that the preadipocyte cell line DFAT derived from mature adipocytes could change into fully differentiated osteoblasts in vitro and in vivo only in the presence of RA.
Several reports have demonstrated that RA induces increases in ALP activity and OC mRNA expression with matrix mineralization in primary osteoblasts (Ng et al., 1988; Heath et al., 1989) and cultured MSCs in rat and mouse (Gazit et al., 1993) . To clarify if RA induces osteogenesis of DFAT cells, we evaluated the effect of RA on expression of ALP and OC, and matrix mineralization. RA induced the expression of ALP, an early marker of osteoblast differentiation, in confluent DFAT cells (Fig. 1A) . Elevation of ALP was rapid and significant, peaking four days after treatment of RA (Fig. 1) . Thereafter, matrix mineralization, a late marker of osteoblast differentiation, increased in a time-dependent manner (Fig. 2) . RA-induced ECM calcification was accompanied by significant promotion of OC production in the late stage of the osteogenic process (Fig. 2C) . These results indicate that DFAT cells were fully converted into mature osteoblasts by transient RA treatment, in accordance with previous reports.
Owen et al. (Owen et al., 1990) formulated the following three stages of osteoblastic differentiation: 1) proliferation, 2) synthesis and maturation of matrix, and 3) mineraliza- tion. These stages are associated with different levels of ALP and OC gene expression and matrix mineralization. ALP gene expression was significantly increased from stage 1 to 2. ALP gene expression was significantly depressed, whereas OC was increased from stage 2 to 3 (Owen et al., 1990) . This formulation is supported by several osteogenesis studies (Harris et al., 1994; Nefussi et al., 1997; Yamamoto et al., 2002; Yamamoto et al., 2003; Siggelkow et al., 2004) . The ALP and OC mRNA expression patterns in DFAT cells in the present study were very similar to their reports. These agreements suggest that DFAT cells accomplish a normal osteogenic differentiation similar to the primary osteoblasts.
BMPs, which are members of the transforming growth factor-β (TGF-β) superfamily, play important parts in the induction of osteogenesis and osteoblast differentiation in vivo (Wang et al., 1990) and of the differentiation of primary osteoblasts and several cell lines of osteogenic precursor cells to differentiate into cells with osteogenic phenotype in vitro (Thies et al., 1992; Rickard et al., 1994; Chen et al., 1995; Harris et al., 1995; Ghosh-Choudhury et al., 1996) . Because BMP-2 may be related to the osteogenic differentiation of DFAT cells, we examined the expression of BMP-2 in osteogenic differentiation of DFAT cells. Interestingly, BMP-2 was expressed in DFAT cells after expression of osteogenic marker genes, as reported to be induced by exogenous BMP-2 in osteogenic differentiation (Fig. 4A) . Gene expression of BMP-2 corresponded to initiation of matrix mineralization (Figs. 2 and 4) . BMP-2 seems to be a regulator of terminal differentiation and the mineralization phase (Rickard et al., 1994) and its effect is also dependent on differentiation stage (Centrella et al., 1995) .
These findings and our report suggest that the expression of endogenous BMP-2 in the osteogenesis of DFAT cells is necessary for matrix mineralization of cells that are committed to osteogenic lineage.
We previously reported that DFAT cells express the early markers of adipocyte differentiation, i.e., SREBP-1c, LPL, and C/EBPβ and δ, before adipogenic induction, and that they can differentiate into adipocytes within 48 h of adipogenic induction (Nobusue et al., 2008) . It was thought that DFAT cells have a strong ability to differentiate into adipocytes. We examined the adipocyte markers of DFAT cells when they were treated by RA. RA did not induce adipocyte differentiation, including major adipocyte markers such as PPARγ2, C/EBPα, and GLUT4 (Fig. 4B ) and proteins as well as cytoplasmic lipid accumulation (Fig. 3) in DFAT cells. Expression of C/EBPβ and δ were not repressed by RA treatment in the DFAT cell. The adipocyte differentiation program is regulated by the sequential expression of transcriptional activators, mainly PPAR families (Kawada et al., 2000) . PPARγ2 is found almost exclusively in adipose tissues, and has been linked to adipocyte differentiation (Tontonoz et al., 1995) . Combined expression of PPARγ2 and C/EBPα has synergistic effects on the promotion of adipocyte conversion in myoblasts (Dalei and Lazar, 1997) , showing that these genes are very important for lipid accumulation in adipocytes. Expression of C/EBPβ and δ were not influenced by RA treatment and were consistently expressed in the DFAT cell. Similar results were observed by Schwarz et al. (Schwarz et al., 1997) , who reported that RA does not prevent C/EBPβ induction, but blocks the induction of PPARγ2 and C/EBPα, thereby reducing adipogenesis. These results suggest that the negative effect of RA on adipogenesis was accompanied by the reduction of PPARγ2 and C/EBPα expression in DFAT cells. Retinoids regulate cellular functions by binding to intracellular RAR or RXR, and RA selectively binds to RAR, leading to the formation of an RAR-RXR heterodimer (Suryawan and Hu, 1997) . The nature of the cross-talk of RA actions between RARs, RXRs, and PPARs via coactivators in adipose tissues may be important for adipogenesis (Kawada et al., 2000) . DiRenzo et al. reported that PPARγ and RAR share the same RXR heterodimerizing partner, and in the presence of RA, it is possible that RAR-RXR heterodimers may be favored over PPARγ-RXR heterodimers (DiRenzo et al., 1997) . Our data, together with these results, suggest that the non-inductive action of adipocyte differentiation by RA is exhibited through RAR upregulation, which was accompanied by non-expression of PPARγ2-induced transcriptional activity. Orimo and Shimada (Orimo and Shimada, 2005) showed that RXR and RARs bound to the RARE and suggested that the complex enhanced ALP expression. Escalante-Alcalde et al. (Escalante-Alcalde et al., 1996) also showed that regulation of the murine ALP gene by RA is probably via a RARE in the gene's promoter region. They showed that, in murine embryonic stem cells, transcriptional activity of the 5'-upstream promoter region of exon 1A, which corresponds to human exon 1B, was upregulated by RA through a putative RARE (Escalante-Alcalde et al., 1996) . These reports suggest that the RAR upregulation by RA strongly promotes osteogenesis by upregulation of RAR-RXR heterodimer-induced transcriptional activity of RARE in ALP promoter region. Our results show a close relationship between DFAT adipogenesis and osteogenesis, and that increased commitment toward bone formation occurs with a concomitant decrease in adipogenic capacity.
Scaffolds or layers of calcium phosphate are widely used as biomaterials in bone tissue engineering. Several investigations have shown that calcium phosphate surfaces have a beneficial effect on bone osteogenesis in vivo (Lee et al., 2000; Uemura et al., 2003; Mauney et al., 2005) . These reports cannot exclude the possibility that recipient-derived cells were contained in the transplantation of scaffolds for regeneration of bone. Sun et al. reported that the vascularization of transplanted bone tissue can occur by ingrowth of host blood vessels, or to originate within transplanted bone tissue (Sun et al., 2007) . Yamaguchi et al. (Yamaguchi et al., 1996) demonstrated that on transplantation, the bone marrow stromal cell line ST2 formed mineralized bone tissue in diffusion chambers. Their results suggest that ST2 cells could mineralize bone tissue without recruitment of host animal-derived MSCs and osteoblasts. We applied this technique to investigate the osteogenic potency of DFAT cells in vivo. Our experiment in a diffusion chamber model revealed that DFAT cells mineralized bone matrix without recruitment of host cells. DFAT cells formed osteoid tissue in vivo after transplantation only by osteogenic induction for four days in vitro before transplantation (Fig. 5) .
Because the osteoid tissue was observed in DFAT cells which were cultured without or with β-glycerophosphoric acid (Fig. 5b, c) , exogenous calcium phosphate is not required. These results indicate that RA-treated DFAT cells were fully converted to mature osteoblasts in vivo.
We hypothesize that the DFAT cell line derived from mature adipocyte could convert into fully differentiated osteoblasts in vitro only by transient RA stimulation, and that it formed osteoid tissue in vivo. Studies of these cellular models may provide a novel approach for studying the commitment mechanism of cell lineage of adipocytes and osteoblasts derived from mesenchymal lineage (Fig. 6) . Although much research concerning cell source for regenerating osteoid tissues and organs has focused on MSCs, we have shown that osteogenic/adipogenic progenitor cells can be generated from fully differentiated cells (e.g., mature adipocytes). DFAT cells may be applicable to bone tissue engineering strategies and cell-based therapies because DFAT cells are easily isolated from a small amount of adipose tissue and are readily expanded with high purity.
